Literature DB >> 28560468

[Ultra-widefield angiography for retinal vein occlusion : How large is large enough?]

M Storch1, S Bemme2, M Rehak3, H Hoerauf2, N Feltgen2.   

Abstract

BACKGROUND: The introduction of full fundus angiography (FAG) for retinal vein occlusion (RVO) has enriched diagnostic imaging; however, it is unclear how much of the retina has to be visualized to evaluate the risk of neovascularization. We investigated the 102° Spectralis camera to assess if imaging beyond the central 102° is necessary.
METHODS: In this retrospective study we assessed 80 eyes of 80 patients with RVO to analyze central and peripheral ischemia using the ultra-widefield 102° Spectralis camera. The standard viewer software was used to delineate ischemic areas (IA) and to measure the amount of pixels of IA in correlation to the total amount of pixels in the peripheral image.
RESULTS: Among the 80 eyes with RVO there were 51 eyes with ischemic areas (central and/or peripheral), of which IA could be detected in 49 eyes by analyzing a fovea-centered FAG image. The average IA in these 51 eyes was 23.5% of the total image area and 53.7% of disc areas, respectively. DISCUSSION: A fovea-centered FAG image with a 102° angle appears to be sufficient to determine the clinically relevant extent of IA. Old recommendations and imaging methods should be rethought. The 102° Spectralis camera provides a clinically suitable, fast and exact method which might replace old methods to describe and document the extent of ischemia by disc areas.

Entities:  

Keywords:  Fluorecein; Ischemia; Pixels; Retinal vein occlusion; Ultra-widefield angiography

Mesh:

Year:  2018        PMID: 28560468     DOI: 10.1007/s00347-017-0513-z

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  8 in total

1.  Validation of Concentric Rings Method as a Topographic Measure of Retinal Nonperfusion in Ultra-Widefield Fluorescein Angiography.

Authors:  Luke Nicholson; Clara Vazquez-Alfageme; Jayashree Ramu; Ioanna Triantafyllopoulou; Namritha V Patrao; Mahdi Muwas; Farrah Islam; Philip G Hykin; Sobha Sivaprasad
Journal:  Am J Ophthalmol       Date:  2015-09-14       Impact factor: 5.258

2.  Validation of Concentric Rings Method as a Topographic Measure of Retinal Nonperfusion in Ultra-widefield Fluorescein Angiography.

Authors:  Akio Oishi; Frank G Holz
Journal:  Am J Ophthalmol       Date:  2015-10-24       Impact factor: 5.258

3.  Measuring the precise area of peripheral retinal non-perfusion using ultra-widefield imaging and its correlation with the ischaemic index.

Authors:  Colin S Tan; Milton C Chew; Jano van Hemert; Michael A Singer; Darren Bell; SriniVas R Sadda
Journal:  Br J Ophthalmol       Date:  2015-07-01       Impact factor: 4.638

4.  Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study system for evaluation of stereoscopic color fundus photographs and fluorescein angiograms: SCORE Study Report 9.

Authors:  Barbara A Blodi; Amitha Domalpally; Ingrid U Scott; Michael S Ip; Neal L Oden; Julee Elledge; Kelly Warren; Michael M Altaweel; Judy E Kim; Paul C Van Veldhuisen
Journal:  Arch Ophthalmol       Date:  2010-09

5.  Baseline and early natural history report. The Central Vein Occlusion Study.

Authors: 
Journal:  Arch Ophthalmol       Date:  1993-08

6.  Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Branch Vein Occlusion Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1986-01

7.  Comparison of ultra-widefield fluorescein angiography with the Heidelberg Spectralis(®) noncontact ultra-widefield module versus the Optos(®) Optomap(®).

Authors:  Matthew T Witmer; George Parlitsis; Sarju Patel; Szilárd Kiss
Journal:  Clin Ophthalmol       Date:  2013-02-21

Review 8.  Update on wide- and ultra-widefield retinal imaging.

Authors:  Samir S Shoughy; J Fernando Arevalo; Igor Kozak
Journal:  Indian J Ophthalmol       Date:  2015-07       Impact factor: 1.848

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.